| PERIOD ENDING | 1-Aug-09 | 2-May-09 | 31-Jan-09 | 1-Nov-08 | | Total Revenue | 1,455,169 | 1,505,296 | 2,082,284 | 1,546,056 | | Cost of Revenue | 1,001,011 | 979,579 | 1,533,673 | 1,046,428 | | | Gross Profit | 454,158 | 525,717 | 548,611 | 499,628 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 410,657 | 428,784 | 499,185 | 504,660 | | Non Recurring | (589) | (68) | 178,634 | 1,988 | | Others | 66,391 | 65,524 | 72,074 | 67,117 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (22,301) | 31,477 | (201,282) | (74,137) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (9,335) |
-
| | Earnings Before Interest And Taxes | (22,301) | 31,477 | (210,617) | (74,137) | | Interest Expense | 19,011 | 18,408 | 12,347 | 22,000 | | Income Before Tax | (41,312) | 13,069 | (222,964) | (96,137) | | Income Tax Expense | (15,040) | 4,650 | (75,970) | (38,900) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (26,657) | 7,663 | (149,348) | (56,070) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (26,657) | 7,663 | (149,348) | (56,070) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| 6,022 | | | Net Income Applicable To Common Shares | ($26,657) | $7,663 | ($149,348) | ($50,048) |
|
0.17% Nasdaq 0.00%
Income Statement
